The effects of light therapy and cognitive behavioral therapy in premenstrual dysphoric disorder (PMDD)

2008 ◽  
Vol 107 ◽  
pp. S86
Author(s):  
J. Haffmans⁎ ◽  
A. Richmond ◽  
F. Landman ◽  
M. Blom
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Premenstrual Dysphoric Disorder ◽  
Light Therapy ◽  
Cognitive Behavioral

Premenstrual syndrome and premenstrual dysphoric disorder: cognitive behavioral therapy as treatment

2017 ◽  
Vol Ano 7 ◽  
pp. 15-23
Author(s):  
Leiliane Aparecida Diniz Tamashiro ◽  
Bianca Cristina Tunes Nakad ◽  
Joel Rennó ◽  
Antônio Geraldo da Silva ◽  
Renan Rocha ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Premenstrual Syndrome ◽  
Behavioral Therapy ◽  
Premenstrual Dysphoric Disorder ◽  
Cognitive Behavioral

Objetivo: Elucidar as principais hipóteses atuais sobre o transtorno disfórico pré-menstrual (TDPM), a síndrome pré-menstrual (SPM) e a terapia cognitiva comportamental (TCC) como tratamento. Método: Foi realizada uma pesquisa nos bancos de dados PubMed, Cochrane e BIREME (LILACS/BVS), nos idiomas português, espanhol e inglês, no período de 2000 a 2017, utilizando os seguintes descritores: transtorno disfórico pré-menstrual, síndrome prémenstrual e terapia cognitiva comportamental. Resultados: Um total de 107 estudos enquadrou-se nos critérios de inclusão – artigos de revisão da literatura, estudos do tipo corte transversal, estudos do tipo coorte prospectivo e estudo do tipo coorte retrospectivo. Cento e cinco estudos identificaram fatores fundamentais para o desenvolvimento da TDPM – as hipóteses da função ovariana, função hormonal, neurotransmissores, genética e fatores ambientais e vulnerabilidade. Desde 2009, temos estudos sobre a TCC como tratamento de primeira linha. Conclusão: Os fundamentos do TDPM podem ser vistos como uma complexa multiplicidade de fatores. Ainda não há nada conclusivo; futuras pesquisas são necessárias para definir os processos etiopatogênicos do TDPM. A TCC demonstrou sua eficácia como tratamento de primeira linha para SPM e TDPM.

scholarly journals Light Enhanced Cognitive Behavioral Therapy (CBT+) for Insomnia and Fatigue During Chemotherapy for Breast Cancer: A Randomized Controlled Trial

2021 ◽  
Author(s):  
Helena R Bean ◽  
Justine Diggens ◽  
Maria Ftanou ◽  
Marliese Alexander ◽  
Lesley Stafford ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Bright Light ◽  
Light Therapy ◽  
Cognitive Behavioral ◽  
Bright Light Therapy ◽  
Patient Reported ◽  
Insomnia Symptoms

Study Objectives Sleep problems are common during chemotherapy for breast cancer (BC). We evaluated whether combined brief cognitive behavioral and bright light therapy (CBT+) is superior to treatment as usual with relaxation audio (TAU+) for insomnia symptoms and sleep efficiency (primary outcomes). Methods We randomized women receiving intravenous chemotherapy, stratified by tumor stage and insomnia severity index (ISI), to 6-weeks CBT+ or TAU+. CBT+ included one in-person session, one telephone call, seven emails, and 20 minutes bright light each morning. TAU+ comprised usual treatment and two emails with relaxation audio tracks. Patient-reported outcomes were assessed at baseline, midpoint (week 3), post (week 6) and 3-month follow-up. Results Women (N = 101) were randomly assigned to CBT+ or TAU+. Insomnia symptoms declined significantly more from baseline to post with CBT+ versus TAU+ (-5.06 vs -1.93, P = .009; effect size [ES] = .69). At 3-month follow-up, both groups had improved insomnia symptoms but did not differ (ES = .18, P = .56). CBT+ had higher patient-reported sleep efficiency than TAU+ after the start of intervention (P = .05) and more improvement in fatigue (ES = .59, P = .013) and daytime sleep-related impairment (ES = .61, P = .009) from baseline to post. Conclusions CBT+ had a clinically significant impact on insomnia and fatigue with moderate effect sizes. Results support offering cognitive behavioral therapy for insomnia and bright light therapy during chemotherapy for breast cancer to help manage sleep and fatigue. Clinical trial information: Registered with the Australian New Zealand Clinical Trials Registry (http://anzctr.org.au/), Registration Number: ACTRN12618001255279

Light Enhanced Cognitive Behavioral Therapy (CBT-I+Light) for Insomnia and Fatigue During Chemotherapy for Breast Cancer: A Randomized Controlled Trial

SLEEP ◽  
2021 ◽  
Author(s):  
Helena R Bean ◽  
Justine Diggens ◽  
Maria Ftanou ◽  
Marliese Alexander ◽  
Lesley Stafford ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Bright Light ◽  
Light Therapy ◽  
Cognitive Behavioral ◽  
Bright Light Therapy ◽  
Patient Reported ◽  
Insomnia Symptoms

Abstract Study Objectives Sleep problems are common during chemotherapy for breast cancer (BC). We evaluated whether combined brief cognitive behavioral and bright light therapy (CBT-I+Light) is superior to treatment as usual with relaxation audio (TAU+) for insomnia symptoms and sleep efficiency (primary outcomes). Methods We randomized women receiving intravenous chemotherapy, stratified by tumor stage and insomnia severity index (ISI), to 6-weeks CBT-I+Light or TAU+. CBT-I+Light included one in-person session, one telephone call, seven emails, and 20 minutes bright light each morning. TAU+ comprised usual treatment and two emails with relaxation audio tracks. Patient-reported outcomes were assessed at baseline, midpoint (week 3), post (week 6) and 3-month follow-up. Results Women (N = 101) were randomly assigned to CBT-I+Light or TAU+. The CBT-I+Light group showed significantly greater improvement in insomnia symptoms than the TAU+ group (-5.06 vs -1.93, P = .009; between-group effect size [ES] = .69). At 3-month follow-up, both groups were lower than baseline but did not differ from each other (between-group ES = .18, P = .56). CBT-I+Light had higher patient-reported sleep efficiency than TAU+ immediately after the start of intervention (P = .05) and significantly greater improvement in fatigue (between-group ES = .59, P = .013) and daytime sleep-related impairment (between-group ES = .61, P = .009) than the TAU+ group. Conclusion CBT-I+Light had a clinically significant impact on insomnia and fatigue with moderate effect sizes. Results support offering cognitive behavioral therapy for insomnia and bright light therapy during chemotherapy for breast cancer to help manage sleep and fatigue.

Abstract P215: Medical Lifestyle Residential Program Reduces Anxiety In 10 Days

Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Francisco E Ramirez ◽  
Payton Heisler ◽  
Neil Nedley
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Light Therapy ◽  
Residential Program ◽  
Cognitive Behavioral ◽  
Mental Condition ◽  
Depression And Anxiety ◽  
Interactive Lectures ◽  
Long Term Follow Up ◽  
The Moment

Introduction: Anxiety is a condition that can lower the quality of life of an individual. Hypothesis: It is proposed that after going through a residential depression and anxiety program, patients could decrease in their anxiety levels. Methods: Participants (n=181), completed a 10-day residential depression and anxiety recovery program in the town of Weimar California. At the beginning of the program, the participants were given different mental condition tests including the Beck Anxiety Inventory Version II (BAI-II) to determine baseline conditions. The BAI-II test refers to levels of depression in four categories: Minimal(0-7), Mid(8-15), Moderate(16-25), Severe(26-63). While participating in the program, the patients partook of exercise therapy, light therapy, interactive lectures with health professionals, plant based healthy meals, and one on one consultations with appropriate physicians and cognitive behavioral therapy from clinical counselors as well as chaplaincy care to deal with other stress sources. Patients also read books on cognitive behavioral therapy. Results: At baseline mean Beck Anxiety was 18.22, SD 11.86, median 16, mode 11. At the end of the program the mean Beck Anxiety score was 7.4, SD 7.7, median 4, mode 0. The change was significant with a t(180) = 13.8 p<.001. Conclusion: The residential medical residential program was very effective in decreasing anxiety. Long term follow up is being done at the moment.

Sign in / Sign up

Export Citation Format

Share Document